From San Francisco to Leipzig – the 1st Annual European BioPharma Obesity Innovation Forum is launching in Europe on June 11-12.

After its success in the USA this spring, the Sachs Forum (#Sachs_EBOIF ) is coming to Leipzig to spread further awareness on the challenges of the global obesity pandemic. The conference is being held at The Westin Leipzig, with the Virtual Week scheduled for June 18-19. The conference will not only provide valuable insights into GLP-1 innovation, combinations, new foundational therapies, and precision medicine. It will also address issues surrounding manufacturing in the industry. Attendees will gain a broad understanding of Europe’s market and its role in shaping global innovation. Find out more at www.sachsforum.com